Norbert Vey

Centre de Recherche en Cancérologie de Marseille

Also affiliated with Institut Paoli-Calmettes

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia”.

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM‐3 antibody, in combination with decitabine or azacitidine in high‐ or very high‐risk myelodysplastic syndromes

American Journal of Hematology(2023)10.1002/ajh.27161

N/A

0.587DataRank · unranked

49 citations

Jordi Esteve, Kimmo Porkka, Steven Knapper, Elie Traer, Sebastian Scholl +22 more

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance

Cancers(2021)10.3390/cancers13225608

N/A

0.489DataRank · unranked

25 citations

Colombe Saillard, Yosr Hicheri, Marie-Anne Hospital, Norbert Vey, Sylvain Garciaz